Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial vol 398, pg 1965, 2021)

被引：0
|
作者：
Abu Dayyeh, B. K.
Maselli, D. B.
Rapaka, B.
机构：
来源：
LANCET | 2021年 / 398卷 / 10315期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1964 / 1964
页数：1
相关论文
共 50 条
  • [1] Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial
    Abu Dayyeh, Barham K.
    Maselli, Daniel B.
    Rapaka, Babusai
    Lavin, Thomas
    Noar, Mark
    Hussan, Hisham
    Chapman, Christopher G.
    Popov, Violeta
    Jirapinyo, Pichamol
    Acosta, Andres
    Vargas, Eric J.
    Storm, Andrew C.
    Bazerbachi, Fateh
    Ryou, Marvin
    French, Matthew
    Noria, Sabrena
    Molina, Daniel
    Thompson, Christopher C.
    [J]. LANCET, 2021, 398 (10315): : 1965 - 1973
  • [2] Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial
    Roth, Christian L.
    Scimia, Cecilia
    Shoemaker, Ashley H.
    Gottschalk, Michael
    Miller, Jennifer
    Yuan, Guojun
    Malhotra, Sonali
    Abuzzahab, M. Jennifer
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (06): : 380 - 389
  • [3] Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial (vol 6, pg 292, 2021)
    Adamson, D.
    Byrne, A.
    Porter, C.
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (04): : E3 - E3
  • [4] Inased (inhaled sedation in ICU) trial protocol: a multicentre randomised open-label trial
    Bailly, Pierre
    Egreteau, Pierre-Yves
    Ehrmann, Stephan
    Thille, Arnaud W.
    Guitton, Christophe
    Grillet, Guillaume
    Reizine, Florian
    Huet, Olivier
    Jaber, S.
    Nowak, Emmanuel
    L'her, Erwan
    [J]. BMJ OPEN, 2021, 11 (02):
  • [5] Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial (vol 398, pg 121, 2021)
    Borobia, A. M.
    Carcas, A. J.
    Perez-Olmeda, M.
    [J]. LANCET, 2021, 398 (10300): : 582 - 582
  • [6] Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial (vol 381, pg 205, 2013)
    Liou, J. M.
    Chen, C. C.
    Chen, M. J.
    [J]. LANCET, 2013, 381 (9874): : 1276 - 1276
  • [7] Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)
    Gyselinck, Iwein
    Liesenborghs, Laurens
    Belmans, Ann
    Engelen, Matthias M.
    Betrains, Albrecht
    Quentin Van Thillo
    Pham Anh Hong Nguyen
    Goeminne, Pieter
    Soenen, Ann-Catherine
    De Maeyer, Nikolaas
    Pilette, Charles
    Papleux, Emmanuelle
    Vanderhelst, Eef
    Derweduwen, Aurelie
    Alexander, Patrick
    Bouckaert, Bernard
    Martinot, Jean-Benoit
    Decoster, Lynn
    Vandeurzen, Kurt
    Schildermans, Rob
    Verhamme, Peter
    Janssens, Wim
    Vos, Robin
    [J]. ERJ OPEN RESEARCH, 2022, 8 (01)
  • [8] Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study (vol 5, pg 500, 2017)
    Beigel, J. H.
    Teblas, P.
    Elie-Turenne, M-C
    Danko, Janine
    [J]. LANCET RESPIRATORY MEDICINE, 2017, 5 (07): : E26 - E26
  • [9] Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial (vol 398, pg 843, 2021)
    Yu, L-M
    Bafadhel, M.
    Dorward, J.
    [J]. LANCET, 2021, 398 (10303): : E12 - E12
  • [10] Shunting outcomes in communicating hydrocephalus: protocol for a multicentre, open-label, randomised controlled trial
    Sun, Tong
    Cui, Wenyao
    Yang, Jingguo
    Yuan, Yikai
    Li, Xuepei
    Yu, Hang
    Zhou, Yicheng
    You, Chao
    Guan, Junwen
    [J]. BMJ OPEN, 2021, 11 (08):
12345